Commonwealth Equity Services LLC Buys 4,732 Shares of Agilent Technologies, Inc. $A

Commonwealth Equity Services LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 13.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,337 shares of the medical research company’s stock after acquiring an additional 4,732 shares during the period. Commonwealth Equity Services LLC’s holdings in Agilent Technologies were worth $5,489,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its position in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after purchasing an additional 769 shares during the last quarter. Geneos Wealth Management Inc. increased its position in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC increased its position in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $273,000.

Agilent Technologies Trading Down 2.1%

Shares of A opened at $135.51 on Friday. The business has a 50-day moving average of $118.35 and a 200 day moving average of $128.35. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm has a market cap of $38.27 billion, a P/E ratio of 27.21, a price-to-earnings-growth ratio of 2.41 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the firm posted $1.31 EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on A. Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their target price for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, Royal Bank Of Canada assumed coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $161.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.